JPRN-UMIN000015857
Completed
未知
Research on a Quantitative Assessment of Skin Symptoms Caused by Chemotherapy Using Molecular Target Drugs - Quantitative Assessment of Skin Symptoms Caused by Chemotherapy Using Molecular Target Drugs
ational Cancer Center Hospital, Appearance Support Center0 sites60 target enrollmentDecember 5, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- on-small-cell lung cancer and colorectal cancer
- Sponsor
- ational Cancer Center Hospital, Appearance Support Center
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients who have skin symptoms that influence skin functions such as atopic dermatitis. 2\) Patients who receive treatments that influence skin functions such as steroids and antibacterial drugs. 3\) Patients who are unable to control dependence. 4\) Patients who are unable to respond to self\-completed questionnaires. 5\) Physicians decide it is inappropriate for the patients to participate in this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluation study of skin character and condition using wearable skin biosensorsSkin diseaseJPRN-UMIN000036932Keio University School of Medicine50
Not yet recruiting
Phase 1
A study to evaluate the safety and tolerability of multiple formulations of an investigational transdermal patch in healthy volunteersACTRN12619000574145INC Research Australia Pty Ltd24
Completed
Not Applicable
A study for the skin functioHealthy adultsJPRN-UMIN000034693Kao Corporation24
Not yet recruiting
Not Applicable
A pilot study on the cutaneous toxicities in oncology patients on Epidermal Growth Factor Receptor inhibitors: skin physiology, clincial manifestations and quality of life.Cutaneous side effects on oncology patients on EGFRIsSkin - Normal skin development and functionACTRN12608000265370inda Wang15
Not yet recruiting
Not Applicable
Human Repeat Insult Patch Test (HRIPT).CTRI/2024/01/061664Zydus Lifesciences Limited